SCHRODER INVESTMENT MANAGEMENT GROUP - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 1 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$16,964,000
+119.3%
249,107
+2.9%
0.03%
+133.3%
Q2 2022$7,736,000
-17.3%
242,142
-9.5%
0.01%0.0%
Q1 2022$9,349,000
+97.9%
267,482
+65.8%
0.01%
+100.0%
Q4 2021$4,723,000
+79.7%
161,346
+56.4%
0.01%
+50.0%
Q3 2021$2,628,000
-12.0%
103,138
+20.9%
0.00%0.0%
Q2 2021$2,987,000
+45.8%
85,305
+69.7%
0.00%
+33.3%
Q1 2021$2,048,000
-44.0%
50,265
-40.4%
0.00%0.0%
Q4 2020$3,656,000
-22.2%
84,392
+2.4%
0.00%
-62.5%
Q3 2020$4,698,000
+38.3%
82,421
+53.2%
0.01%
+33.3%
Q2 2020$3,397,000
+76.9%
53,802
+60.9%
0.01%
+50.0%
Q1 2020$1,920,000
-22.9%
33,442
+6.8%
0.00%0.0%
Q4 2019$2,490,000
+61.3%
31,3270.0%0.00%
+33.3%
Q3 2019$1,544,000
-2.0%
31,327
+4.5%
0.00%0.0%
Q2 2019$1,576,000
+8.3%
29,967
+9.0%
0.00%0.0%
Q1 2019$1,455,00027,4850.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 356,270$24,262,00023.36%
Twin Securities, Inc. 376,669$25,651,00011.94%
Paradigm Biocapital Advisors LP 1,175,879$80,077,00010.68%
Chicago Capital Management, LLC 246,246$16,769,0009.12%
HARVEST MANAGEMENT LLC 141,500$9,636,0007.78%
Fernwood Investment Management, LLC 174,724$11,899,0005.02%
ArchPoint Investors 168,725$11,490,0004.69%
HAVENS ADVISORS LLC 46,000$3,133,0004.69%
Perceptive Advisors 2,322,247$158,145,0004.59%
Crabel Capital Management, LLC 112,680$7,674,0004.48%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders